(Q58212024)

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Overview of angiogenesis: Biologic implications for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Genes that regulate metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Lipid messengers as targets for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Tumour vasculature as a target for anticancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Molecular mechanism of angiogenesis transcription factors and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The hemostatic system as a regulator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The role of collagen-derived proteolytic fragments in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Galectin-3 induces endothelial cell morphogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Current status of antiangiogenic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Tie receptors: new modulators of angiogenic and lymphangiogenic responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Fibroblast growth factors, their receptors and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Identification of an angiogenic mitogen selective for endocrine gland endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Thrombospondins and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Human SPRY2 inhibits FGF2 signalling by a secreted factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Oncogenes and angiogenesis: signaling three-dimensional tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

PTEN controls tumor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The role of HER2 in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Circulating endothelial precursors: mystery, reality, and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Origins of circulating endothelial cells and endothelial outgrowth from blood

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Intussusceptive angiogenesis: its role in embryonic vascular network formation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Vasculogenic mimicry and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Role of Id proteins in embryonic and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Homeobox B3 promotes capillary morphogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The ephrins and Eph receptors in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Eph receptors and ephrin ligands. essential mediators of vascular development.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

In silico cloning of novel endothelial-specific genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Angiogenesis: the role of the microenvironment in flipping the switch.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

A conserved family of prolyl-4-hydroxylases that modify HIF

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Transcriptional response to hypoxia in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Involvement of platelets in tumour angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Targeting tumor angiogenesis with gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Tissue-specific gene therapy directed to tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Targeting gene expression to hypoxic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Monoclonal antibody strategies to block angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

NMR imaging of changes in vascular morphology due to tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Antiangiogenic agents and their promising potential in combined therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Angiogenesis is redundant for tumour growth in lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Matrix metalloproteinases: pro- and anti-angiogenic activities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021

Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6349%2803%2900007-7

7 January 2021